Insmed Inc (INSM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2019 | |
Sales | 305,208 | 245,358 | 188,461 | 164,413 | 136,467 |
Cost of Goods | 65,573 | 55,126 | 44,152 | 39,872 | 24,212 |
Gross Profit | 239,635 | 190,232 | 144,309 | 124,541 | 112,255 |
Operating Expenses | 949,834 | 647,679 | 519,555 | 390,645 | 347,712 |
Operating Income | -709,626 | -457,321 | -375,094 | -265,232 | -235,245 |
Interest Expense | 81,694 | 26,446 | 40,473 | 29,564 | 27,705 |
Other Income | 44,308 | 3,616 | -20,845 | 2,108 | 9,390 |
Pre-tax Income | -747,012 | -480,151 | -436,412 | -292,688 | -253,560 |
Income Tax | 2,555 | 1,383 | -1,758 | 1,402 | 777 |
Net Income Continuous | -749,567 | -481,534 | -434,654 | -294,090 | -254,337 |
Net Income | $-749,567 | $-481,534 | $-434,654 | $-294,090 | $-254,337 |
EPS Basic Total Ops | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 |
EPS Basic Continuous Ops | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 |
EPS Diluted Total Ops | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 |
EPS Diluted Continuous Ops | -5.34 | -3.91 | -3.88 | -3.01 | -3.01 |
EPS Diluted Before Non-Recurring Items | -5.34 | -3.90 | -3.75 | -3.01 | -3.01 |
EBITDA(a) | $-689,015 | $-441,039 | $-328,795 | $-229,626 | $-205,322 |